亚谐波辅助压力估测无创评估颅内压:犬实验研究
在实验犬硬膜外置入乳胶球并注射生理盐水,建立11 mm Hg至50 mm Hg的颅内压动态变化模型,脑实质内压力传感器记录颅内压,每次颅内压稳定后行亚谐波辅助压力估测(SHAPE)获取亚谐波造影增强超声(SHCEUS)参数。基底静脉亚谐波振幅与颅内压负相关(r=-0.798),SHAPE梯度与颅内压正相关(r=0.628)。按颅脑创伤颅内压监测指南定义20、25、30 mm Hg为界值,基底静脉亚谐波振幅诊断颅内高压的AUC分别为0.867、0.884、0.875,SHAPE梯度分别为0.839、0.842、0.794。作者认为SHAPE技术可辅助评估犬颅内压变化。
要点
- 犬实验中将乳胶球置入硬膜外并注射生理盐水,建立11 mm Hg至50 mm Hg的颅内压动态模型,脑实质内压力传感器记录颅内压。
- 基底静脉亚谐波振幅与颅内压负相关(r=-0.798),SHAPE梯度(颅内动脉亚谐波振幅减基底静脉亚谐波振幅)与颅内压正相关(r=0.628)。
- 按颅脑创伤颅内压监测指南定义20、25、30 mm Hg为界值,基底静脉亚谐波振幅诊断颅内高压≥20、≥25、≥30 mm Hg的AUC分别为0.867(95%CI 0.750-0.943)、0.884(95%CI 0.770-0.954)、0.875(95%CI 0.759-0.948)。
- SHAPE梯度诊断颅内高压≥20、≥25、≥30 mm Hg的AUC分别为0.839(95%CI 0.716-0.924)、0.842(95%CI 0.720-0.926)、0.794(95%CI 0.665-0.890)。
- 作者认为SHAPE技术可辅助评估犬颅内压变化,为评估颅内压提供新思路和方法。
适用人群与场景
- 实验犬,通过硬膜外置入乳胶球并注射生理盐水建立颅内压11 mm Hg至50 mm Hg动态变化模型。
诊断标准与关键阈值
- 参照颅脑创伤患者颅内压监测指南,定义20 mm Hg、25 mm Hg、30 mm Hg为颅内高压诊断界值。
研究设计与关键结果
- 实验犬研究:硬膜外乳胶球注入生理盐水建立颅内压11 mm Hg至50 mm Hg动态模型,脑实质内压力传感器记录颅内压,每次颅内压稳定后行SHAPE获取SHCEUS参数(基底静脉与邻近颅内动脉亚谐波振幅及SHAPE梯度)。
- 基底静脉亚谐波振幅与颅内压负相关(r=-0.798),SHAPE梯度与颅内压正相关(r=0.628)。
- 基底静脉亚谐波振幅诊断颅内高压≥20 mm Hg、≥25 mm Hg、≥30 mm Hg的AUC分别为0.867(95%CI 0.750-0.943)、0.884(95%CI 0.770-0.954)、0.875(95%CI 0.759-0.948)。
- SHAPE梯度诊断颅内高压≥20 mm Hg、≥25 mm Hg、≥30 mm Hg的AUC分别为0.839(95%CI 0.716-0.924)、0.842(95%CI 0.720-0.926)、0.794(95%CI 0.665-0.890)。
证据类型、等级与局限
- 证据类型:犬实验研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为SHAPE技术可辅助评估犬颅内压变化,为评估颅内压提供新思路和方法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Intracranial hypertension is a common clinicopathological syndrome in neurosurgery, and a timely understanding of the intracranial pressure (ICP) may help guide clinical treatment. We aimed to investigate the correlation between subharmonic contrast-enhanced ultrasound (SHCEUS) parameters and ICP in experimental canines.
METHODS: A dynamic model of ICP change from 11 mm Hg to 50 mm Hg was established in experimental canines by placing a latex balloon into the epidural space and injecting saline into the balloon. In addition, a pressure sensor was placed in the brain parenchyma to record the changes in ICP. When the ICP stabilized after each increase, subharmonic-aided pressure estimation (SHAPE) technology was performed to obtain the SHCEUS parameters, including the basal venous and adjacent intracranial arterial subharmonic amplitude and SHAPE gradient (subharmonic amplitude in the intracranial artery minus that in the basal vein). The correlation between these parameters and ICP was analyzed.
RESULTS: The subharmonic amplitude of the basal vein was negatively correlated with the ICP (r = -0.798), and the SHAPE gradient was positively correlated with the ICP (r = 0.628). According to the guidelines for ICP monitoring in patients with traumatic brain injury, we defined 20 mm Hg, 25 mm Hg, and 30 mm Hg as the cutoff ICP levels. The area under the receiver operating characteristic curve of the basal venous subharmonic amplitude for diagnosing intracranial hypertension ≥20 mm Hg, ≥25 mm Hg, and ≥30 mm Hg was 0.867 (95% confidence interval [CI], 0.750-0.943), 0.884 (95% CI, 0.770-0.954), and 0.875 (95% CI, 0.759-0.948), respectively. The area under the receiver operating characteristic curve of the SHAPE gradient for diagnosing intracranial hypertension ≥20 mm Hg, ≥25 mm Hg, and ≥30 mm Hg was 0.839 (95% CI, 0.716-0.924), 0.842 (95% CI, 0.720-0.926), and 0.794 (95% CI, 0.665-0.890), respectively.
CONCLUSION: SHCEUS parameters are correlated with ICP. The SHAPE technique can assist in evaluating ICP changes in canines, which provides a new idea and method for evaluating ICP.
参考来源
- Zheng S, Zhang Y, Cheng L, et al. Noninvasive assessment of intracranial pressure using subharmonic-aided pressure estimation: An experimental study in canines. J Trauma Acute Care Surg. 2022. PMID: 35687796. doi:10.1097/TA.0000000000003720
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。